The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

LCTX FINANCIAL STATEMENTS

Lineage Cell Therapeutics Inc — balance sheet, income statement and cash flow trends

LCTXLineage Cell Therapeutics Inc

🇺🇸 USA · AMEX · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M-25 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue13.1 M $Gross Profit12.6 M $ · 97%Operating Income-26.9 M $ · -205%Pre-tax Income-37.4 M $ · -286%Net Income to Owners-32.3 M $ · -247%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue13.1 M $+19.9%
Gross Profit12.6 M $+18.7%
Operating Income-26.9 M $—
EBITDA-36.6 M $—
Net Income to Owners-32.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M150 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets106.2 M
  • Equity60.9 M $57%
  • Current Liabilities8 M $7%
  • Long-term Liabilities38.4 M $36%

Key Figures

YoY change
Total Assets106.2 M $+17.0%
Total Liabilities46.4 M $+6.3%
Total Equity60.9 M $+25.9%
Cash & ST Investments50.8 M $+20.2%
Total Debt2.3 M $+6.7%
Net Debt-35.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M0-23.8 M $Operating-13.7 M $Investing32.2 M $Financing-5.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-23.8 M $—
Capital Expenditures233 K $-60.4%
Free Cash Flow-23.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LCTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.